Efficacy of Mepolizumab in Chinese Severe Asthma Patients on Medium-Dose Inhaled Corticosteroids

被引：0

作者：

Lipworth, Brian ^{[1
]}

Washko, George ^{[2
]}

Saralaya, Dinesh ^{[3
]}

Zhang, Mei ^{[4
]}

Soler, Xavier ^{[5
]}

Rowe, Paul ^{[4
]}

Deniz, Yamo ^{[5
]}

Gomez, Lucia De Prado ^{[6
]}

Sacks, Harry

Jacob-Nara, Juby ^{[4
]}

机构：

[1] Univ Dundee, Scottish Ctr Resp Res, Dundee, Scotland

[2] Brigham & Womens Hosp, Boston, MA USA

[3] Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Bradford, England

[4] Sanofi, Bridgewater, NJ USA

[5] Regeneron Pharmaceut Inc, Tarry Town, NY USA

[6] Sanofi, Madrid, Spain

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2025年 / 155卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

937

引用

页码：AB306 / AB306

页数：1

共 50 条

[1] The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial
Paggiaro, Pierluigi
Halpin, David M. G.
Buhl, Roland
Engel, Michael
Zubek, Valentina B.
Blahova, Zuzana
Moroni-Zentgraf, Petra
Pizzichini, Emilio
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (01): : 104 - +
[2] Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose
Pavord, Ian D.
Bourdin, Arnaud
Papi, Alberto
Domingo, Christian
Corren, Jonathan
Altincatal, Arman
Radwan, Amr
Pandit-Abid, Nami
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul J.
Laws, Elizabeth
Lederer, David J.
Hardin, Megan
ALLERGY, 2023, 78 (11) : 2921 - 2932
[3] REDUCTIONS IN EXACERBATIONS AND IMPROVEMENTS IN LUNG FUNCTION AND ASTHMA CONTROL IN CHILDREN WITH MODERATE-TO-SEVERE TYPE 2 ASTHMA ANALYZED BY HIGH- OR MEDIUM-DOSE OF INHALED CORTICOSTEROIDS AT BASELINE
Maspero, J.
Antila, M. A.
Jain, N.
Deschildre, A.
Bacharier, L. B.
Altincatal, A.
Laws, E.
Akinlade, B.
Siddiqui, S.
Jacob-Nara, J. A.
Deniz, Y.
Rowe, P. J.
Lederer, D. J.
Hardin, M.
VALUE IN HEALTH, 2022, 25 (12) : S34 - S35
[4] Efficacy of inhaled corticosteroids in asthma
Barnes, PJ
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) : 531 - 538
[5] The influence of Adherence to inhaled Corticosteroids (ICS) on treatment Response to mepolizumab treatment in severe Eosinophilic asthma
Almutairi, Mohammed
Marriott, John
Jalal, Zahraa
Wood, Louise
Almoosawi, Batool
Caddick, Samantha
Rajkumari, Babita
Renwick, Susan
Wilkinson, Siobhan
Gallagher, Caroline
Duffin, Thomas
Mansur, Adel
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[6] Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Crimi, Claudia
Campisi, Raffaele
Cacopardo, Giulia
Doria, Giacomo
Intravaia, Rossella
Morena, Porto
Sabrina, Genco
Sorrentino, Ramona
Crimi, Nunzio
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[7] Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 μg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids
Nathan, Robert A.
Nolte, Hendrik
Pearlman, David S.
ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (04) : 269 - 279
[8] Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis
Wang, Liqun
Zhou, Ruirui
Xie, Xiaohui
JOURNAL OF ASTHMA, 2019, 56 (01) : 69 - 78
[9] Effects of combined mometasone furoate and formoterol (200/10 μg BID) on the incidence of moderate and severe exacerbation in subjects with moderate asthma previously using medium-dose inhaled corticosteroids
Nathan, R.
Nolte, H.
Pearlman, D.
ALLERGY, 2010, 65 : 553 - 553
[10] Severe Asthma Patients in Korea Overestimate Their Adherence to Inhaled Corticosteroids
Bae, Yun-Jeong
Kim, Tae-Bum
Jee, Young-Koo
Park, Heung-Woo
Chang, Yoon-Seok
Cho, Sang-Heon
Cho, You Sook
Moon, Hee-Bom
JOURNAL OF ASTHMA, 2009, 46 (06) : 591 - 595

← 1 2 3 4 5 →